Cargando…
Antinociceptive properties of losmapimod in two acute pain models in rats: behavioural analysis, immunohistochemistry, dose response, and comparison with usual analgesic drugs()
BACKGROUND: The p38 protein is a ubiquitous mitogen-activated protein kinase involved in the proinflammatory signalling pathway and in the pain response after various noxious stimuli. Many p38 inhibitors have been developed and shown to provide effective analgesia in animal models. They are, however...
Autores principales: | Soued, Mickaël, Hamdi, Leila, Ben Rehouma, Mouna, Mazoit, Jean-Xavier, Benhamou, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430813/ https://www.ncbi.nlm.nih.gov/pubmed/37588580 http://dx.doi.org/10.1016/j.bjao.2022.100029 |
Ejemplares similares
-
Parietal Block Using Bupivacaine in the Rat: An Anatomical, Behavioral and Histological Study
por: Kfoury, Toni T, et al.
Publicado: (2020) -
Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
por: Nishimura, Yukio
Publicado: (2018) -
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
por: Gipson, Debbie S., et al.
Publicado: (2020) -
Identification of a clinical compound losmapimod that blocks Lassa virus entry
por: Zhang, Xiaoyu, et al.
Publicado: (2019) -
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
por: Yeung, Yiu To, et al.
Publicado: (2018)